Methotrexate + infliximab vs infliximab
Withdrawals due to adverse events · adult patients with refractory Crohn's disease
Methotrexate + infliximab showed no clear difference in withdrawals due to adverse event (Feagan 2014) compared with infliximab alone (low certainty).
1 finding from 1 review
- Methotrexate for induction of remission in refractory Crohn's disease 2014 · Cochrane Headline outcomes onlyRR 2 [0.19, 21.5]1 study · 126 participantsLow